Rafaele Dumas

966 total citations
16 papers, 747 citations indexed

About

Rafaele Dumas is a scholar working on Hepatology, Infectious Diseases and Epidemiology. According to data from OpenAlex, Rafaele Dumas has authored 16 papers receiving a total of 747 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Hepatology, 9 papers in Infectious Diseases and 8 papers in Epidemiology. Recurrent topics in Rafaele Dumas's work include Hepatitis Viruses Studies and Epidemiology (10 papers), Viral gastroenteritis research and epidemiology (7 papers) and Hepatitis B Virus Studies (6 papers). Rafaele Dumas is often cited by papers focused on Hepatitis Viruses Studies and Epidemiology (10 papers), Viral gastroenteritis research and epidemiology (7 papers) and Hepatitis B Virus Studies (6 papers). Rafaele Dumas collaborates with scholars based in France, Germany and Austria. Rafaele Dumas's co-authors include Grenville Marsh, F Hofmann, Jean Lang, Bruno Guy, Mark A. Fletcher, Luc Hessel, Rémi Forrat, Laurent Chambonneau, Nicolas Burdin and Nolwenn Nougarede and has published in prestigious journals such as Antimicrobial Agents and Chemotherapy, Vaccine and American Journal of Tropical Medicine and Hygiene.

In The Last Decade

Rafaele Dumas

16 papers receiving 726 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Rafaele Dumas France	12	431	356	271	239	133	16	747
Alexander Rosewell Australia	16	227 0.5×	344 1.0×	122 0.5×	201 0.8×	62 0.5×	49	736
Theano Georgakopoulou Greece	17	299 0.7×	296 0.8×	231 0.9×	225 0.9×	58 0.4×	51	735
Alenka Kraigher Slovenia	14	342 0.8×	398 1.1×	153 0.6×	222 0.9×	21 0.2×	40	788
Irene Barrabeig Spain	17	421 1.0×	429 1.2×	79 0.3×	125 0.5×	91 0.7×	71	848
Stefan Hagmann United States	17	237 0.5×	114 0.3×	406 1.5×	86 0.4×	158 1.2×	46	649
Maria Grazia Pompa Italy	18	280 0.6×	417 1.2×	240 0.9×	190 0.8×	67 0.5×	37	822
Julia Lynch United States	14	300 0.7×	133 0.4×	179 0.7×	43 0.2×	62 0.5×	42	626
Sunil Bahl India	17	728 1.7×	283 0.8×	119 0.4×	214 0.9×	32 0.2×	60	1.1k
Sékéné Badiaga France	18	495 1.1×	264 0.7×	293 1.1×	119 0.5×	49 0.4×	53	1.0k
Allison Taylor Walker United States	10	142 0.3×	131 0.4×	144 0.5×	118 0.5×	36 0.3×	33	434

Countries citing papers authored by Rafaele Dumas

Since Specialization

Citations

This map shows the geographic impact of Rafaele Dumas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rafaele Dumas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rafaele Dumas more than expected).

Fields of papers citing papers by Rafaele Dumas

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rafaele Dumas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rafaele Dumas. The network helps show where Rafaele Dumas may publish in the future.

Co-authorship network of co-authors of Rafaele Dumas

This figure shows the co-authorship network connecting the top 25 collaborators of Rafaele Dumas. A scholar is included among the top collaborators of Rafaele Dumas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rafaele Dumas. Rafaele Dumas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Guy, Bruno, Véronique Barban, Nathalie Mantel, et al.. (2009). Evaluation of Interferences between Dengue Vaccine Serotypes in a Monkey Model. American Journal of Tropical Medicine and Hygiene. 80(2). 302–311. 114 indexed citations

Guy, Bruno, Nolwenn Nougarede, Violette Sanchez, et al.. (2008). Cell-mediated immunity induced by chimeric tetravalent dengue vaccine in naive or flavivirus-primed subjects. Vaccine. 26(45). 5712–5721. 117 indexed citations

Hofmann, F, et al.. (2006). Influenza Vaccination of Healthcare Workers: a Literature Review of Attitudes and Beliefs. Infection. 34(3). 142–147. 288 indexed citations

López, Eduardo, María M Contrini, Betzana Zambrano, et al.. (2006). Hepatitis A vaccination of Argentinean infants: Comparison of two vaccination schedules. Vaccine. 25(1). 102–108. 14 indexed citations

Overbosch, D., et al.. (2006). Combined Typhoid Fever and Hepatitis A Vaccine: Comparison of Immunogenicity and Safety to Concomitant Monovalent Vaccine over 3 Years. Journal of Travel Medicine. 12(6). 319–326. 27 indexed citations

Bailleux, Fabrice, et al.. (2004). Aventis Pasteur Vaccines Containing Inactivated Hepatitis A Virus: A Compilation of Immunogenicity Data. European Journal of Clinical Microbiology & Infectious Diseases. 23(4). 300–309. 21 indexed citations

Loebermann, Micha, Herwig Kollaritsch, Pamela Rendi‐Wagner, et al.. (2004). A randomized, open-label study of the immunogenicity and reactogenicity of three lots of a combined typhoid fever/hepatitis A vaccine in healthy adults. Clinical Therapeutics. 26(7). 1084–1091. 11 indexed citations

Lagos, Rosanna, Alma Muñoz, Rafaele Dumas, et al.. (2003). Immunological priming of one dose of inactivated hepatitis A vaccine given during the first year of life in presence of maternal antibodies. Vaccine. 21(25-26). 3730–3733. 18 indexed citations

Dumas, Rafaele, et al.. (2001). Safety and immunogenicity of a pediatric formulation of inactivated hepatitis A vaccine in Argentinean children. The Pediatric Infectious Disease Journal. 20(1). 48–52. 28 indexed citations

10.

Lee, Chin‐Yun, et al.. (2000). Immunogenicity and safety of an inactivated hepatitis A vaccine in Taiwanese adults and children.. PubMed. 31(1). 29–36. 9 indexed citations

11.

Zambrano, Betzana, et al.. (1999). Safety, immunogenicity and antibody persistence of an inactivated hepatitis A vaccine in 4 to 15 year old children. Vaccine. 18(7-8). 656–664. 14 indexed citations

12.

Hessel, Luc, et al.. (1999). Experience With Salmonella typhi Vi Capsular Polysaccharide Vaccine. European Journal of Clinical Microbiology & Infectious Diseases. 18(9). 609–620. 61 indexed citations

13.

Theamboonlers, Apiradee, et al.. (1998). Immunogenicity and safety of a new inactivated hepatitis A vaccine in Thai young adults.. PubMed. 29(4). 779–85. 4 indexed citations

14.

Forrat, Rémi, Rafaele Dumas, Michael Seiberling, et al.. (1998). Evaluation of the Safety and Pharmacokinetic Profile of a New, Pasteurized, Human Tetanus Immunoglobulin Administered as Sham, Postexposure Prophylaxis of Tetanus. Antimicrobial Agents and Chemotherapy. 42(2). 298–305. 5 indexed citations

15.

Dumas, Rafaele, et al.. (1997). Safety and immunogenicity of a new inactivated hepatitis A vaccine in concurrent administration with a typhoid fever vaccine or a typhoid fever + yellow fever vaccine.. PubMed. 14(4). 160–7. 15 indexed citations

16.

Dumas, Rafaele, et al.. (1982). [Coxsackie B virus neuropapillitis (author's transl)].. PubMed. 53(5). 473–82. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact